CYP3A4 and hypothyroidism: Apalutamide, a potent CYP3A4 inducer, is thought to stimulate the hepatic activity of UDP-glucuronyl transferase via activation of the PXR nuclear receptor, leading to increased clearance of T4 with a decrease in its systemic concentration and hypothyroidism (3).